NCT03400007

Brief Summary

Pelvic organ prolapsed, associated with defecation disorders and urinary tracts symptoms are common and affect up to 25% of the population, mostly parous women. The pelvic floor must be seen as one entity, with multiple anatomical and physiological interactions between the various compartments (rectum, vagina, uterus and bladder) which are embedded in the same anatomical region. The often complex pathologies of this region should therefore be treated in a multidisciplinary setting. Besides clinical evaluation, functional dynamic imaging of anorectal and pelvic floor disfunctions has an important role in the diagnosis and management of these disorders. Although the colpocystodefecography is still considered to be the golden standard in imaging this complex anatomical region, there is clearly a need for more precise imaging of the structural details, preferentially without any irradiation. Transperineal ultrasound is an option but the investigators have chosen to evaluate the use of dynamic magnetic resonance imaging. In contrast to colpocystodefecography, dynamic pelvic floor magnetic resonance imaging is an evolving technology and its precise role in functional imaging of the pelvic floor still remains to be determined. Prolapse surgery is commonly performed and therefore it is important to assess the efficacy of the operations in correcting the anatomical defects and the symptoms associated without creating new, pelvic floor related symptoms. Few studies exist today allowing the assessment of the anatomical changes and symptoms after surgery, through abdominal or perineal approach. This study will evaluate the reliability of the dynamic pelvic floor imaging, done in a sitting position, compared to colpocystodefecography, done in a sitting position. It will also compare clinical objective and subjective results related to pelvic floor abnormalities with imaging. Finally, it will evaluate the anatomical changes in correlation with the clinical results, organ position and inter-compartments relationships after surgery. This study will allow to understand and explain some relapses and failures and could lead to an improvement of the indications for surgery and surgical techniques used.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2017

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2017

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 17, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 26, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 26, 2021

Completed
Last Updated

July 19, 2022

Status Verified

July 1, 2022

Enrollment Period

4 years

First QC Date

January 9, 2018

Last Update Submit

July 18, 2022

Conditions

Keywords

dynamic floor magnetic resonance imagingcolpocystodefecagraphyprolapse surgery

Outcome Measures

Primary Outcomes (8)

  • recto-anal angle -relax position

    Measured by dynamic floor MRI in left lateral decubitus position (141°)

    6 months post surgery

  • recto-anal angle -retain position

    Measured by dynamic floor MRI in left lateral decubitus position (163°)

    6 months post surgery

  • recto-anal angle -push position

    Measured by dynamic floor MRI in left lateral decubitus position (165°)

    6 months post surgery

  • recto-anal angle -relax position

    Measured by dynamic floor MRI in sitting position (141°)

    6 months post surgery

  • recto-anal angle -retain position

    Measured by dynamic floor MRI in sitting position (125°)

    6 months post surgery

  • recto-anal angle -push position

    Measured by dynamic floor MRI in sitting position (143°)

    6 months post surgery

  • Dynamic MRI: anterior compartment

    From the bladder, discrete inferior descent of the pubococcygeal line: max 1/3 (yes/no)

    6 months post surgery

  • Dynamic MRI: medium compartment

    Vagina horizontalization (yes/no)

    6 months post surgery

Secondary Outcomes (5)

  • Fecal Incontinence Severity Index (FISI)

    6 months post surgery

  • Constipation scoring system (CCS)

    6 months post surgery

  • Prolapse Quality of Life (P-QOL) questionnaire

    6 months post surgery

  • Sexual function questionnaire (PISQ-IR)

    6 months post surgery

  • Visual analogic Scale (VAS)

    6 months post surgery

Study Arms (1)

Prolapse surgery

Device: Dynamic floor magnetic resonance imagingDevice: Colpocystodefecography

Interventions

Dynamic floor magnetic resonance imaging (MRI)

Prolapse surgery

Colpocystodefecography (CCD)

Prolapse surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients who will be operated for symptomatic rectal intussusception or prolapse, enterocele and/or urogenital prolapse, though abdominal and persineal approach as well.

You may qualify if:

  • All patients who will undergo internal or external rectal prolapse, enterocele or urogenital prolapse surgery in CHU Brugmann and CHU St Pierre.

You may not qualify if:

  • MRI contra-indications
  • Patients with prior pelvic floor surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

CHU Brugmann

Brussels, 1020, Belgium

Location

CHU St Pierre

Brussels, Belgium

Location

MeSH Terms

Conditions

Prolapse

Condition Hierarchy (Ancestors)

Pathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Katleen Jottard, MD

    CHU Brugmann

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Head of clinic

Study Record Dates

First Submitted

January 9, 2018

First Posted

January 17, 2018

Study Start

November 1, 2017

Primary Completion

October 26, 2021

Study Completion

October 26, 2021

Last Updated

July 19, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will not share

Locations